Patents by Inventor Thomas Magee

Thomas Magee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070161681
    Abstract: Compounds useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructive pulmonary disease, of the formula: wherein the substituents are as defined in the specification.
    Type: Application
    Filed: January 30, 2007
    Publication date: July 12, 2007
    Applicants: PFIZER INC., PFIZER PRODUCTS INC.
    Inventors: Anthony Marfat, Robert Chambers, Thomas Magee
  • Publication number: 20060135447
    Abstract: Macrolide compounds per se, as shown below and defined herein, and their use, e.g., as antibacterial and antiprotozoal agents in animals, including humans: Also disclosed are methods of preparing the compounds, intermediates, and pharmaceutical compositions thereof, and methods of treating or preventing disease by administering the compounds to subjects in need. This abstract is only an excerpt and is not limiting of the invention.
    Type: Application
    Filed: December 21, 2005
    Publication date: June 22, 2006
    Inventors: Louis Chupak, Mark Flanagan, Takushi Kaneko, Thomas Magee, Mark Noe, Usa Reilly
  • Publication number: 20060014780
    Abstract: The invention relates to nicotinamide derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The nicotinamide derivatives according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic, respiratory diseases, disorders and conditions, as well as wounds.
    Type: Application
    Filed: September 16, 2005
    Publication date: January 19, 2006
    Inventors: Simon Bailey, Elisabeth Gautier, Alan Henderson, Thomas Magee, Anthony Marfat, John Mathias, Dale McLeod, Sandra Monaghan, Blanda Stammen
  • Publication number: 20050049258
    Abstract: This application is directed to compounds of the formula wherein j is 1; k is 0 or 1; m is 1, 2 or 3; n is 1 or 2; W1 and W2 are independently —O— or —S(?O)t—, where t is 0, 1, or 2; Y is ?C(R1a)—, where R1a is a member selected from the group consisting of H; F; Cl; CN; NO2; —(C1-C4)alkyl; —(C2-C4)alkynyl; fluorinated-(C1-C3)alkyl; fluorinated-(C1-C3)alkoxy; —OR16; and —C(?O)NR22aR22b; R22a and R22b are defined as set forth in the specification; —RA and RB are each a member independently selected from the group consisting of H; F; CF3; —(C1-C4)alkyl; —(C3-C7)cycloalkyl; phenyl; and benzyl; wherein said cycloalkyl, phenyl, and benzyl moieties are each independently substituted with 0 to 3 substituents R10, which is defined as set forth in the specification; R16 and R17 are defined as set forth in the specification; —RC and RD have the same meaning as defined above for RA and RB except that one of them must be —H, and they are selected independently of each other and of RA and RB; R1 and R2 are each a mem
    Type: Application
    Filed: August 13, 2004
    Publication date: March 3, 2005
    Inventors: Anthony Marfat, Robert Chambers, Thomas Magee